ANI PHARMACEUTICALS, INC Cash Provided by (Used in) Operating Activities, Discontinued Operations
ANI PHARMACEUTICALS, INC (ANIP) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-23.
Discontinued › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2016-02-23
- ANI PHARMACEUTICALS, INC cash provided by (used in) operating activities, discontinued operations for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- ANI PHARMACEUTICALS, INC cash provided by (used in) operating activities, discontinued operations for the quarter ending 2013-12-31 was $44.00K.
- ANI PHARMACEUTICALS, INC cash provided by (used in) operating activities, discontinued operations for the quarter ending 2013-09-30 was -$234.62K.
- ANI PHARMACEUTICALS, INC cash provided by (used in) operating activities, discontinued operations for the quarter ending 2012-12-31 was -$76.08K.
- ANI PHARMACEUTICALS, INC cash provided by (used in) operating activities, discontinued operations for fiscal 2015 was $0.00.
- ANI PHARMACEUTICALS, INC cash provided by (used in) operating activities, discontinued operations for fiscal 2014 was $0.00.
- ANI PHARMACEUTICALS, INC cash provided by (used in) operating activities, discontinued operations for fiscal 2013 was -$195.00K.
- ANI PHARMACEUTICALS, INC cash provided by (used in) operating activities, discontinued operations for fiscal 2012 was -$142.00K.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month as first filed | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month |
|---|---|---|---|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-02-23 | ||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $0.00 10-K · filed 2016-02-23 | |||
| 2014-09-30 | $0.00 10-Q · filed 2014-11-10 | ||||
| 2013-12-31 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | -$190.62K derived: sum of 2 quarters · filed 2016-02-23 | -$195.00K 10-K · filed 2016-02-23 | ||
| 2013-09-30 | -$234.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$239.00K 10-Q · filed 2014-11-10 | -$88.82K 10-Q · filed 2013-11-07 | ||
| 2013-06-30 | -$4.38K 10-Q · filed 2013-08-09 | ||||
| 2012-12-31 | -$76.08K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | -$91.45K derived: sum of 2 quarters · filed 2014-02-28 | -$142.00K 10-K · filed 2014-02-28 | ||
| 2012-09-30 | -$15.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$65.92K 10-Q · filed 2013-11-07 | |||
| 2012-06-30 | -$50.55K 10-Q · filed 2013-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |